@misc{misc, title  = {{SELPAC: A 3 arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel (PT) in metastatic uveal melanoma (UM)}},

 url = {{https://doi.org/10.1093/annonc/mdz394.070 }},

 year = {{2019}},

 month = {{10}},

 author = {{Nathan P and Needham A and Corrie PG and Danson S and Evans J and Ochsenreither S and Kumar S and Goodman A and Larkin JMG and Karydis I and Steven NM et al}},

 doi = {{10.1093/annonc/mdz394.070}},

 volume = {{30}},

 journal = {{Annals of Oncology}},

 pages = {{v908-v910}},

 note = {{Accessed on 2025/11/09}}}